FDA’s ‘Breakthrough’ Nod to MM120, An LSD-Derivative, for Anxiety Relief
LOS ANGELES- In a significant development within the field of psychedelic therapy, the Food and Drug Administration (FDA) has recognized the LSD-analog substance MM120,...
Red Light Holland Advances in Psilocybin Microdosing Capsules for Australasian Market
NEW YORK – Red Light Holland Corp., a leader in the production and distribution of functional mushrooms and psilocybin truffles, has announced significant progress...
DEA Proposes Increased Production Quotas for Cannabis and Psychedelics
LOS ANGELES- In a significant policy shift, the Drug Enforcement Administration (DEA) has proposed substantial increases in the production quotas for cannabis and various...
Rhode Island Explores Psilocybin Reform with a New Legislative Proposal
NEW TORK- In a significant legislative move, Rhode Island Representative Brandon Potter (D) has introduced a bill aimed at reforming the state's approach to...
DEA Clarifies Legality of Psychedelic Mushroom Spores, Highlighting Regulatory Complexities
WASHINGTON, D.C. — The U.S. Drug Enforcement Administration (DEA) recently provided a crucial clarification on the legal status of psychedelic mushroom spores. According to...
